NCT00567619已完成不适用
LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 900
- 试验地点
- 1
研究概览
简要总结
Evaluate burden of disease in Patients with newly occurred upper GI symptoms related to GERD (symptom frequency & severity, QoL, lifestyle modifications, self-medication) - baseline data according to GERD impact scale presenting to specialists, especially internists
- Evaluate effect of treatment with a acid suppressive therapy on these parameters: looking for improvement of symptom burden and quality of life according to the GERD impact sca
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with newly occured upper GI symptoms related to GERD
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for ResponseGastroesophageal RefluxNCT00392002AstraZeneca2,000
Unknown
不适用
Symptom Inventory for Gastrointestinal Stromal TumorsGastrointestinal Stromal TumorsNCT01178307M.D. Anderson Cancer Center187
已完成
不适用
Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese PopulationGastroesophageal Reflux DiseaseNCT00165022Chinese University of Hong Kong330
已完成
不适用
Correlates of GERD Symptom SeverityGERDNCT03020550Massachusetts General Hospital24
已完成
不适用
Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of LifeReflux Esophagitis (RE)Non-erosive Reflux Disease (NERD)Functional Heartburn (FH)NCT01536080Seoul National University Bundang Hospital207